Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
17
VERA Quote, Financials, Valuation and Earnings
Last price:
$41.82
Seasonality move
:
28.97%
Day range:
$41.53 - $42.87
52-week range:
$14.20 - $51.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
9.27x
Volume:
333.1K
Avg. volume:
578.9K
1-year change:
166.94%
Market cap:
$2.7B
Revenue:
--
EPS (TTM):
-$2.61
Earnings Data
Next earnings date for VERA
May 09
2025
Most recent earnings per share
-$0.85
Missed by $0.24
(Nov 7/2024)
Consensus Estimate
-$0.61
(Nov 7/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
VERA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2024 | Q4 | -- | -- | -- | -$0.73 | -- |
| 11/07/2024 | Q3 | -- | -- | -$0.85 | -$0.61 | -$0.24 |
| 08/08/2024 | Q2 | -- | -- | -$0.62 | -$0.54 | -$0.08 |
| 05/09/2024 | Q1 | -- | -- | -$0.56 | -$0.54 | -$0.02 |
| 03/28/2024 | Q4 | -- | -- | -$0.58 | -$0.51 | -$0.07 |
| 11/09/2023 | Q3 | -- | -- | -$0.45 | -$0.54 | $0.09 |
| 08/10/2023 | Q2 | -- | -- | -$0.46 | -$0.74 | $0.28 |
| 05/11/2023 | Q1 | -- | -- | -$0.80 | -$0.45 | -$0.35 |
| 03/28/2023 | Q4 | -- | -- | -$1.19 | -$0.90 | -$0.29 |
| 11/09/2022 | Q3 | -- | -- | -$0.91 | -$0.90 | -$0.01 |
| 08/10/2022 | Q2 | -- | -- | -$0.55 | -$0.78 | $0.23 |
| 05/16/2022 | Q1 | -- | -- | -$0.71 | -- | -- |
| 03/24/2022 | Q4 | -- | -- | -$0.79 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$0.36 | -- | -- |
| 08/16/2021 | Q2 | -- | -- | -$0.33 | -- | -- |
| 06/24/2021 | Q1 | -- | -- | -$0.23 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$10.52 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$1.09 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.88 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.61 | -- | -- |
Vera Therapeutics Earnings Questions
-
How Much did Vera Therapeutics Generate in Revenue Last Quarter?
Vera Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Vera Therapeutics Beat Earnings Last Quarter?
Vera Therapeutics announced earnings per share of -$0.85 which represents a miss of analyst forecast a -$0.61 per share.
-
Is Vera Therapeutics Profitable?
Vera Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Vera Therapeutics EPS Next Year?
Vera Therapeutics's earnings are forecast to decrease from -$2.25 per share to -$2.18 per share next year representing a decrease of -19.85%.
-
When is Vera Therapeutics's Earnings Date?
Vera Therapeutics's next earnings date is May 9, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 7.46% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.66% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.53% over the past day.
